Statistical Methods for Dose‐Finding Experiments
From MaRDI portal
Collections of articles of miscellaneous specific interest (00B15) Proceedings, conferences, collections, etc. pertaining to statistics (62-06) Applications of statistics to biology and medical sciences; meta analysis (62P10) Biochemistry, molecular biology (92C40) Medical applications (general) (92C50)
Recommendations
- Dose-finding designs for early-phase cancer clinical trials. A brief guidebook to theory and practice
- Statistical Issues in Drug Development
- Handbook of methods for designing, monitoring, and analyzing dose-finding trials
- Introduction to statistical methods for clinical trials.
- Adaptive design theory and implementation using SAS and R.
Cited in
(27)- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials
- Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors
- Adaptive clinical trial designs for phase I cancer studies
- Cumulative cohort design for dose-finding
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents
- Adaptive Bayesian compound designs for dose finding studies
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control
- Statistical methods in drug combination studies
- Semiparametric Dose Finding Methods
- On multi-armed bandit designs for dose-finding trials
- Dose Finding – A Challenge in Statistics
- Dose-finding designs for early-phase cancer clinical trials. A brief guidebook to theory and practice
- Dose-finding methods for phase I clinical trials using pharmacokinetics in small populations
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
- Statistics in clinical and observational vaccine studies
- Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
- Performance Measures in Dose‐Finding Experiments
- A straightforward meta-analysis approach for oncology phase I dose-finding studies
- Bridging continual reassessment method for phase I clinical trials in different ethnic populations
- Dose finding with longitudinal data: simpler models, richer outcomes
- Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control
- Competing designs for drug combination in phase I dose-finding clinical trials
- Model-based dose finding under model uncertainty using general parametric models
- A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials
- Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities
- Two-stage dose finding for cytostatic agents in phase I oncology trials
- On the choice of doses for phase III clinical trials
This page was built for publication: Statistical Methods for Dose‐Finding Experiments
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3426056)
